165 related articles for article (PubMed ID: 37025638)
1. Modulation of the nanoscale motion rate of
Starodubtseva MN; Chelnokova IA; Shkliarava NM; Villalba MI; Tapalski DV; Kasas S; Willaert RG
Front Microbiol; 2023; 14():1133027. PubMed ID: 37025638
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
3. Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
Yu PK; Moron-Espiritu LS; Lao AR
mSystems; 2022 Dec; 7(6):e0069122. PubMed ID: 36383015
[TBL] [Abstract][Full Text] [Related]
4. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
[TBL] [Abstract][Full Text] [Related]
8. Increasing Susceptibility of Drug-Resistant
Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of fluconazole, itraconazole, and voriconazole activity on
Partha ADSL; Widodo ADW; Endraswari PD
Ann Med Surg (Lond); 2022 Dec; 84():104882. PubMed ID: 36536737
[TBL] [Abstract][Full Text] [Related]
10. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
Khodavandi A; Alizadeh F; Vanda NA; Karimi G; Chong PP
Pharm Biol; 2014 Dec; 52(12):1505-9. PubMed ID: 24863276
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
12. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
14. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
[TBL] [Abstract][Full Text] [Related]
15. Antifungal Activity and Potential Mechanism of N-Butylphthalide Alone and in Combination With Fluconazole Against
Gong Y; Liu W; Huang X; Hao L; Li Y; Sun S
Front Microbiol; 2019; 10():1461. PubMed ID: 31312187
[No Abstract] [Full Text] [Related]
16. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against
Chen X; Shi Y; Li Y; Su S; Wang P; Sun S
Expert Rev Anti Infect Ther; 2021 Jan; 19(1):109-115. PubMed ID: 32924656
[TBL] [Abstract][Full Text] [Related]
17. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition.
Zhu B; Li Z; Yin H; Hu J; Xue Y; Zhang G; Zheng X; Chen W; Hu X
Microbiol Spectr; 2022 Apr; 10(2):e0147821. PubMed ID: 35297651
[TBL] [Abstract][Full Text] [Related]
19. Titration of C-5 Sterol Desaturase Activity Reveals Its Relationship to Candida albicans Virulence and Antifungal Susceptibility Is Dependent upon Host Immune Status.
Regan J; DeJarnette C; Luna-Tapia A; Parker JE; Reitler P; Barnett S; Tucker KM; Kelly SL; Palmer GE
mBio; 2022 Apr; 13(2):e0011522. PubMed ID: 35380453
[TBL] [Abstract][Full Text] [Related]
20. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
Li Y; Yang J; Li X; Su S; Chen X; Sun S; Li Y
Int J Antimicrob Agents; 2020 Aug; 56(2):106030. PubMed ID: 32454072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
